Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gratwohl

Showing results (341-350 of 381) with videos related to

Pageof 39
Sort By:
Bone Marrow Transplantation|January 27, 2004
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmesS McCann, J L Byrne, M Rovira, et al.
Bone Marrow Transplantation|March 7, 1998
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationV Runde, T de Witte, R Arnold, et al.
Infection|July 18, 2012
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantationA Egli, C Bucher, A Dumoulin, et al.
Blood|May 29, 2000
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationC Guglielmi, W Arcese, J Hermans, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Bone Marrow Transplantation|June 19, 1998
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationN Schmitz, A Bacigalupo, D Hasenclever, et al.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
Bone Marrow Transplantation|May 4, 2010
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approachJ Halter, Wmm Schüpbach, C Casali, et al.
British Journal of Haematology|June 1, 1997
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg gradeP A Rowlings, D Przepiorka, J P Klein, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Pageof 39

Showing results (341-350 of 381) with videos related to

Sort By:
Pageof 39
Bone Marrow Transplantation|January 27, 2004
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmesS McCann, J L Byrne, M Rovira, et al.
Bone Marrow Transplantation|March 7, 1998
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationV Runde, T de Witte, R Arnold, et al.
Infection|July 18, 2012
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantationA Egli, C Bucher, A Dumoulin, et al.
Blood|May 29, 2000
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationC Guglielmi, W Arcese, J Hermans, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Bone Marrow Transplantation|June 19, 1998
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationN Schmitz, A Bacigalupo, D Hasenclever, et al.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
Bone Marrow Transplantation|May 4, 2010
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approachJ Halter, Wmm Schüpbach, C Casali, et al.
British Journal of Haematology|June 1, 1997
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg gradeP A Rowlings, D Przepiorka, J P Klein, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Pageof 39